Skip to content

Effect of Dexmedetomidine combined esketamine on Postpartum Depression in Women With Prenatal Depression

Effect of Dexmedetomidine combined esketamine on Postpartum Depression in Women With Prenatal Depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089799
Enrollment
Unknown
Registered
2024-09-14
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

Experimental group: dexmedetomidine was given 0.5ug/kg, and 100 ml of 0.9% normal saline was infused for 15min after delivery. After operation, PCIA was given sufentanil 1.5 ug/kg+dexmedetomidine 2 ug
control group:100 ml of 0.9% normal saline was given after delivery. After operation, PCIA was given sufentanil 1.5 ug/kg and tropisetron 4mg.

Sponsors

Jiangxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The participants were parturients who underwent elective cesarean delivery under spinal anesthesia and required postoperative patient-controlled intravenous analgesia (PCIA).Inclusion criteria were as follows: 18 years of age or older, prenatal depression (defined as a prenatal Edinburgh Postnatal Depression Scale [EPDS] score >9)

Exclusion criteria

Exclusion criteria: Exclusion criteria: Dexmedetomidine or Esketamine allergic patients, heart rate less than 50 beats /min, patients with abnormal heart conduction or rhythm, unstable history of mental illness or psychotropic substance abuse, excessive blood loss during operation, transfer to ICU, and serious diseases such as heart, lung, liver and kidney.

Design outcomes

Primary

MeasureTime frame
incidence of positive PPD screening results at 42 days post partum ;

Secondary

MeasureTime frame
incidence of positive PPD screening results at 24h and 3 days post partum and EPDS score;Adverse events at 6h, 24h and 48h postpartum.;

Countries

China

Contacts

Public ContactHeguo Luo

Department of Anesthesiology, Jiangxi Provincial People's Hospital

1596450316@qq.com+86 138 0703 5516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026